NOVIRUSES2BRAIN: A project to develop drugs capable of crossing physiological barriers to attack viruses

NOVIRUSES2BRAIN team, represented by David Andreu and Toni Todorovski, researchers at MELIS-UPF, gave an interview at Ellipse magazine. During this interview they talked about the main goal of the project, which is to develop a drug capable of attacking viruses that reach the brain and cross the placenta; highlighted how important it is for our society to find this type of antiviral drug, as well as the promising results obtained so far. In addition, they revealed the biggest challenges of the project and the next steps to overcome these barriers and obtain these drugs.

To learn more about the project, please follow this link: